Bird flu vaccine made in powder form

Dec 26, 2007

A researcher in the Netherlands has created an avian flu vaccine in powder form.

The powdered form of the drug could prove to be a great weapon against avian flu since it can be stored and transported at room temperature. Current liquid vaccines need to be refrigerated, making it harder to transport into poor and developing countries, Radio Netherlands reported Tuesday.

Jean-Pierre Amorij of the University of Groningen, the man behind the idea, said a powder flu vaccine would be the only means of preventing many deaths in the case of a serious epidemic.

"The powder has particular advantages when it comes to transport and preservation because it can be kept at room temperature. The current flu vaccines are in liquid form, which means that you need refrigeration to transport and store them. This is an enormous problem in the developing countries," he said.

Copyright 2007 by United Press International

Explore further: FDA approves hard-to-abuse narcotic painkiller

add to favorites email to friend print save as pdf

Related Stories

Food choices can affect antibiotic's effectiveness

Nov 19, 2010

When your child needs antibiotics, dietary choices can get complicated. Food can help support the body nutritionally and hinder the effectiveness of the medication, depending on what your child eats and when.

New research assesses use of Tamiflu, Relenza to prevent flu

Aug 03, 2009

Two common anti-influenza drugs — Relenza and Tamiflu — appear equally effective at preventing common flu symptoms when given before infection, say researchers from the Stanford University School of Medicine. However, ...

Major flu strain resistant to widely used antiviral drug

Jan 15, 2009

One of the major strains of the influenza virus this season has become resistant to Tamiflu - rendering the mainstay antiviral drug all but impotent and creating tough treatment options for patients who come down with the ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments : 0